LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Dose‐adjusted EPOCH‐R is a safe and well tolerated outpatient treatment regimen in double‐hit lymphoma

Photo from wikipedia

Double‐hit lymphoma (DHL) is an aggressive subtype of high‐grade B‐cell lymphoma with inferior prognosis using standard dose chemotherapy. Controversy remains whether more intensive chemotherapy regimens such as dose‐adjusted etoposide, prednisolone,… Click to show full abstract

Double‐hit lymphoma (DHL) is an aggressive subtype of high‐grade B‐cell lymphoma with inferior prognosis using standard dose chemotherapy. Controversy remains whether more intensive chemotherapy regimens such as dose‐adjusted etoposide, prednisolone, vincristine, cyclophosphamide, doxorubicin and rituximab (DA‐EPOCH‐R) provide better outcomes in this cohort.

Keywords: hit lymphoma; double hit; dose adjusted; adjusted epoch; epoch safe

Journal Title: Internal Medicine Journal
Year Published: 2022

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.